Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SUMITOMO CHEMCL (SOMMY : OTC)
 
 • Company Description   
Sumitomo Chemical Co., Ltd. engages in the manufacture and sale of chemicals. Its operating segments consists of Basic Chemicals, Petrochemicals and Plastics, Information Technology related Chemicals, Health and Crop Sciences, Pharmaceuticals and Others. Basic Chemicals segment produces organic and inorganic chemicals, synthetic fiber raw materials, methyl methacrylate products, alumina products, additives and dyestuffs. Petrochemicals and Plastics segment consists of synthetic resin, rubber and other resin processed products. IT-Related Chemicals segment sells optical products, color filters, semiconductor processing materials, compound semiconductor materials and battery components. Health and Crop Sciences segment distributes fertilizers, pesticides, insecticides, tropical infectious disease control materials and feed additives. Pharmaceuticals segment develops and sells ethical pharmaceuticals, radiopharmaceutical and radiation therapy equipment. Others segment provides supply of electrical power and stea

Number of Employees: 34,743

 
 • Price / Volume Information   
Yesterday's Closing Price: $20.55 Daily Weekly Monthly
20 Day Moving Average: 34,761 shares
Shares Outstanding: 331.09 (millions)
Market Capitalization: $6,803.88 (millions)
Beta: 0.86
52 Week High: $28.50
52 Week Low: $20.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.02% 5.10%
12 Week -15.26% -4.76%
Year To Date -12.85% 6.47%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
27-1 Shinkawa 2-chome
-
Tokyo,M0 104-8260
JPN
ph: 813-5543-5102
fax: 813-5543-5901
None http://www.sumitomo-chem.co.jp
 
 • General Corporate Information   
Officers
Keiichi Iwata - President
Masakazu Tokura - Chairman
Hiroshi Ueda - Executive Vice President
Hiroshi Niinuma - Director
Takashi Shigemori - Director

Peer Information
SUMITOMO CHEMCL (EMLIF)
SUMITOMO CHEMCL (GPLB)
SUMITOMO CHEMCL (BCPUQ)
SUMITOMO CHEMCL (CYT.)
SUMITOMO CHEMCL (SOA)
SUMITOMO CHEMCL (AIQUY)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: CHEM-DIVERSIFD
Sector: Basic Materials
CUSIP: 865612105
SIC: 8880
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 331.09
Most Recent Split Date: (:1)
Beta: 0.86
Market Capitalization: $6,803.88 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 3.13%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.64
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.16
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 5.06
PEG Ratio: -
Price Ratios
Price/Book: 0.51
Price/Cash Flow: 4.14
Price / Sales: 0.38
EPS Growth
vs. Year Ago Period: -20.97%
vs. Previous Quarter: -56.64%
Sales Growth
vs. Year Ago Period: -99.92%
vs. Previous Quarter: -99.93%
ROE
03/31/22 - -
12/31/21 - 10.20
09/30/21 - 9.12
ROA
03/31/22 - -
12/31/21 - 3.79
09/30/21 - 3.39
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - 7.48
12/31/21 - 6.07
09/30/21 - 5.40
Net Margin
03/31/22 - 7.48
12/31/21 - 6.07
09/30/21 - 5.40
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©